About Imexpharm
Imexpharm is a company based in Cao Lanh (Vietnam) founded in 1983 was acquired by Livzon Pharmaceutical in May 2025. The company has 1,450 employees as of December 31, 2024.
- Headquarter Cao Lanh, Vietnam
- Employees 1450 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imexpharm Corporation
-
Annual Revenue
$2440 B10.7as on Dec 31, 2025
-
Net Profit
$304.39 B2.3as on Dec 31, 2025
-
EBITDA
$567.15 B8.9as on Dec 31, 2025
-
Latest Funding Round
$8 M (USD), Debt – Conventional
Dec 16, 2020
-
Investors
SK
& 2 more
-
Employee Count
1450
as on Dec 31, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Imexpharm
Imexpharm is a publicly listed company on the HOSE with ticker symbol IMP in Vietnam, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Imexpharm
Unlock access to complete
Funding Insights of Imexpharm
Investors in Imexpharm
Imexpharm has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include SK, Asian Development Bank and Livzon Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Advisory services and financial resources are mobilized for development projects.
|
Locked | Locked | Locked | |
|
Manufacturer drug preparation, bulk medicines, and intermediates
|
Locked | Locked | Locked | |
|
Private equity firm focused on energy, chemical, semiconductor, logistics, and multiple sectors
|
Locked | Locked | Locked |
Investor details for Imexpharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imexpharm
Investment portfolio details for Imexpharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imexpharm
Detailed financials for Imexpharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imexpharm Comparisons
Peer comparison for Imexpharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imexpharm
Detailed competitors of Imexpharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imexpharm
Complete news archive for Imexpharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imexpharm
Imexpharm was founded in 1983 and raised its 1st funding round 37 years after it was founded.
Imexpharm is headquartered in Cao Lanh, Vietnam. It is registered at Cao Lanh, Measure, Vietnam.
As of Dec 31, 2024, the latest employee count at Imexpharm is 1,450.
Imexpharm was founded in 1983 and is based in Cao Lanh, Vietnam. Diversified generic drugs are produced by the company within the pharmaceutical sector. Operations focus on the development and manufacturing of various generic medications to address healthcare needs. Standard production processes are followed to ensure compliance with industry regulations. The companys domain, imexpharm.com, supports its online operations, with activities centered in Vietnam.
Yes, Imexpharm is publicly traded on HOSE under the ticker symbol IMP.
Imexpharm has 3 investors. Key investors include SK, Asian Development Bank, and Livzon Pharmaceutical.
The ticker symbol of Imexpharm is IMP on HOSE.